Ligand Pharmaceuticals Inc (LGND)

Stockholders Equity

$967.52M

Quarterly · Period ending: · USD

LGND logo

LGND Stockholders Equity

Latest reported$967.52M
LGND Quarterly Shareholders Equity ($35.90M → $967.52M)
High-resolution chart · PNG

LGND stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
-45,628,000
-38,228,000
-55,125,000
-30,340,000
-16,809,000
-12,642,000
-25,600,000
-45,000,000
-30,300,000
-15,800,000
-11,400,000
7,300,000
13,700,000
22,800,000
34,300,000
16,100,000
23,100,000
32,200,000
34,500,000
8,500,000
12,700,000
22,200,000
28,100,000
32,700,000
26,100,000
26,300,000
32,700,000
28,500,000
35,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.